Transient hypothyroidism after iodine-131 treatment of Graves' disease. 1989

J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
Servicio de Endocrinologia, Hospital de Bellvitge, Barcelona, España.

One hundred twenty six patients with Graves' disease, 26 with toxic multinodular goiter, and 18 with toxic adenoma were treated with 131I (3-15 mCi), and followed at monthly intervals for six months. Transient hypothyroidism occurred at two months in 22 patients with Graves' disease. In this state TSH levels became elevated in seven patients, but were normal or suppressed in seven. In 17 patients T4 and T3 levels returned to normal without T4 replacement. Five patients developed recurrent thyrotoxicosis, and required repeated doses of 131I. The possibility of transient hypothyroidism in the early months after 131I therapy in Graves' disease should be borne in mind.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013963 Thyroid Hormones Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs. Thyroid Hormone,Hormone, Thyroid,Hormones, Thyroid

Related Publications

J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
April 1998, Clinical endocrinology,
J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
February 1980, The Journal of clinical endocrinology and metabolism,
J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
August 1979, British medical journal,
J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
September 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
September 2000, Annales d'endocrinologie,
J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
January 1997, Clinical endocrinology,
J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
July 2015, European journal of clinical nutrition,
J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
July 2005, Pharmacotherapy,
J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
December 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J M Gómez, and N Virgili, and J Soler, and M Fernández, and E Montaña
April 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!